Can acupuncture with electricity ease cancer brain fog and fatigue?
NCT ID NCT05283577
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether electroacupuncture (a type of acupuncture with mild electrical pulses) can help cancer patients and survivors with clusters of symptoms like memory problems, fatigue, insomnia, anxiety, and depression. Seventy participants will receive either real electroacupuncture or a sham version over 10 weeks. Researchers will track changes in symptoms, cognitive function, and blood biomarkers to see if the treatment is feasible and promising.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- electroacupuncture
- What this could lead to
- If it works, this could offer a non-drug option to help cancer patients and survivors manage common symptoms like brain fog, tiredness, and trouble sleeping.
- What could go wrong
- This is a small early feasibility study, not a large trial. The sham control may also provide some benefit, making it hard to prove real effects. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
70 people
The number who actually took part.
- Started
-
Apr 2022
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients diagnosed with cancer that have received anti-cancer treatment * 16 years of age or older * Life expectancy ≥ 6 months * Complaints of one or more of the following symptoms: memory impairment/attention deficit, fatigue, insomnia, depression, or anxiety over the past 7 days Exclusion Criteria: * Presence of metastasis * Severe needle phobia * Severe psychiatric or medical disorders which would affect cognitive assessments * Known bleeding disorder (e.g. hemophilia, Von Willebrand's disease, thrombocytopenia) * Has pacemaker or other electronic metal implants * Epilepsy * Already receiving acupuncture therapy or received acupuncture treatment in the past 3 months. * Breastfeeding, pregnant or are planning get pregnant during the study period Additional exclusion criteria for optional neuroimaging procedure: \- Has any contraindications to fMRI including metal fragments/implants in the body, sever claustrophobia, and non-removable metal orthodontic braces, metallic retainers and oral wires.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCI Health Susan Samueli Integrative Health Institute
Irvine, California, 92697, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?